Clinical Trial Update: Impact of the Atlas 2030 Pediatric Exoskeleton on Gait Functionality and Quality of Life in Children With Cerebral Palsy or Related Conditions

View source ↗

Summary

A completed clinical trial evaluating the Atlas 2030 pediatric exoskeleton for gait function and quality of life in children with cerebral palsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• ATLAS 2030 pediatric exoskeleton

Snippet

Sponsor: FIDMAG Germanes Hospitalàries | Conditions: Cerebral Palsy Infantile | Status: COMPLETED